171 related articles for article (PubMed ID: 15753055)
1. Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas.
Corazzelli G; Capobianco G; Russo F; Frigeri F; Aldinucci D; Pinto A
Haematologica; 2005 Mar; 90(3):ECR14. PubMed ID: 15753055
[TBL] [Abstract][Full Text] [Related]
2. Hepatosplenic T cell lymphoma responsive to 2'-deoxycoformycin therapy.
Bennett M; Matutes E; Gaulard P
Am J Hematol; 2010 Sep; 85(9):727-9. PubMed ID: 20652973
[TBL] [Abstract][Full Text] [Related]
3. 2'-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma.
Grigg AP
Leuk Lymphoma; 2001 Aug; 42(4):797-9. PubMed ID: 11697510
[TBL] [Abstract][Full Text] [Related]
4. Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin.
Iannitto E; Barbera V; Quintini G; Cirrincione S; Leone M
Br J Haematol; 2002 Jun; 117(4):995-6. PubMed ID: 12060145
[No Abstract] [Full Text] [Related]
5. In vitro and in vivo effects of 2'-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignancies.
Aldinucci D; Poletto D; Zagonel V; Rupolo M; Degan M; Nanni P; Gattei V; Pinto A
Br J Haematol; 2000 Jul; 110(1):188-96. PubMed ID: 10930997
[TBL] [Abstract][Full Text] [Related]
6. Hepatosplenic gamma-delta T-cell lymphoma.
Ferreri AJ; Govi S; Pileri SA
Crit Rev Oncol Hematol; 2012 Aug; 83(2):283-92. PubMed ID: 22047938
[TBL] [Abstract][Full Text] [Related]
7. Development of hepatosplenic gammadelta T-cell lymphoma with pancytopenia during early pregnancy: a case report and review of the literature.
Niitsu N; Kohri M; Togano T; Nakamine H; Nakamura S; Iwabuchi K; Higashihara M
Eur J Haematol; 2004 Nov; 73(5):367-71. PubMed ID: 15458516
[TBL] [Abstract][Full Text] [Related]
8. Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantation.
Gassas A; Kirby M; Weitzman S; Ngan B; Abla O; Doyle JJ
Am J Hematol; 2004 Feb; 75(2):113-4. PubMed ID: 14755380
[TBL] [Abstract][Full Text] [Related]
9. Rare variety of T-cell lymphoma.
Pednekar S; Morge V; Rawal S; Korivi D; Ramteke V; Naik K
J Assoc Physicians India; 2011 Oct; 59():667-8. PubMed ID: 22479752
[TBL] [Abstract][Full Text] [Related]
10. T-cell gamma/delta hepatosplenic lymphoma - prolonged remission induced by aggressive first line treatment.
Procházka V; Papajík T; Jarosová M; Pikalová Z; Indrák K; Tichý M; Kucerová L; Fakan F; Bílý M; Starostka D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):275-6. PubMed ID: 16601770
[TBL] [Abstract][Full Text] [Related]
11. Managing hepatosplenic gammadelta T-cell leukemia-lymphoma in children.
Lo Nigro L; Munda S; Poli A; Licciardello M; D'Amico S; Di Cataldo A
Pediatr Blood Cancer; 2007 Oct; 49(5):763. PubMed ID: 17120239
[No Abstract] [Full Text] [Related]
12. Pentostatin (Nipent) in T-cell lymphomas.
Kurzrock R
Semin Oncol; 2000 Apr; 27(2 Suppl 5):64-6. PubMed ID: 10877055
[TBL] [Abstract][Full Text] [Related]
13. Hepatosplenic gammadelta T-cell lymphoma following seven malaria infections.
Hassan R; Franco SA; Stefanoff CG; Romano SO; Diamond HR; Franco LG; Seuánez HN; Zalcberg IR
Pathol Int; 2006 Nov; 56(11):668-73. PubMed ID: 17040289
[TBL] [Abstract][Full Text] [Related]
14. Hepatosplenic T-cell lymphoma.
Franco V; Florena AM
Br J Haematol; 2001 Jul; 114(1):3. PubMed ID: 11472337
[No Abstract] [Full Text] [Related]
15. The first infant case with hepatosplenic gammadelta T-cell lymphoma after acute disseminated encephalomyelitis (ADEM)-like exacerbation.
Koga SY; Kumaki S; Ichinohasama R; Munakata M; Haginoya K; Ohashi Y; Tanaka Y; Sakamoto O; Minegishi M; Morio T; Iinuma K; Tsuchiya S
J Pediatr Hematol Oncol; 2006 Nov; 28(11):741-5. PubMed ID: 17114961
[TBL] [Abstract][Full Text] [Related]
16. Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma.
Suarez F; Wlodarska I; Rigal-Huguet F; Mempel M; Martin-Garcia N; Farcet JP; Delsol G; Gaulard P
Am J Surg Pathol; 2000 Jul; 24(7):1027-32. PubMed ID: 10895827
[TBL] [Abstract][Full Text] [Related]
17. Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma.
Ooi J; Iseki T; Adachi D; Yamashita T; Tomonari A; Tojo A; Tani K; Asano S
Haematologica; 2001 Oct; 86(10):E25. PubMed ID: 11602432
[No Abstract] [Full Text] [Related]
18. Hepatosplenic gammadelta T-cell lymphoma after liver transplantation: report of the first 2 cases and review of the literature.
Roelandt PR; Maertens J; Vandenberghe P; Verslype C; Roskams T; Aerts R; Nevens F; Dierickx D
Liver Transpl; 2009 Jul; 15(7):686-92. PubMed ID: 19562701
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.
Tey SK; Marlton PV; Hawley CM; Norris D; Gill DS
Am J Hematol; 2008 Apr; 83(4):330-3. PubMed ID: 17876769
[TBL] [Abstract][Full Text] [Related]
20. Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine.
Gopcsa L; Bányai A; Tamáska J; Karádi A; Matolcsy A; Pálóczi K
Haematologia (Budap); 2002; 32(4):519-27. PubMed ID: 12803128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
